Safety and efficacy of yttrium-90 ibritumomab tiuxetan in older patients with non-Hodgkin's lymphoma.
about
Update on the rational use of Y-ibritumomab tiuxetan in the treatment of follicular lymphomaEfficacy and safety of yttrium-90 ibritumomab tiuxetan in Japanese patients with non-Hodgkin lymphoma.90Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma.Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibody.Review of Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin's lymphoma.Novel antibody-based proteins for cancer immunotherapy.Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM.Invasive tracheobronchial aspergillosis developed during radioimmunotherapy for malignant lymphoma.
P2860
Q24633710-4EC12414-39FD-4933-96E4-2DD45317D161Q33402171-861AD379-C011-4235-AE77-01777F0A0F6FQ33416554-70F444C7-9989-474D-8BF4-9BD0BB2CA909Q35115650-967A9FF2-E5B5-4D04-A120-F21D8827B378Q36979699-70F691DA-B143-4839-BE0C-11EA795825EAQ37824258-24361290-9361-4864-8EE7-F4A1D504072FQ38161370-9044CBC9-D6FE-49CD-8B34-FEAD1AFB5F10Q42535831-F6359C0A-A01A-4387-BCE6-DECBAACE2514Q55345291-F4DE5687-B94E-4B07-B2B8-D582DD7EE513
P2860
Safety and efficacy of yttrium-90 ibritumomab tiuxetan in older patients with non-Hodgkin's lymphoma.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Safety and efficacy of yttrium ...... s with non-Hodgkin's lymphoma.
@ast
Safety and efficacy of yttrium ...... s with non-Hodgkin's lymphoma.
@en
type
label
Safety and efficacy of yttrium ...... s with non-Hodgkin's lymphoma.
@ast
Safety and efficacy of yttrium ...... s with non-Hodgkin's lymphoma.
@en
prefLabel
Safety and efficacy of yttrium ...... s with non-Hodgkin's lymphoma.
@ast
Safety and efficacy of yttrium ...... s with non-Hodgkin's lymphoma.
@en
P2093
P356
P1476
Safety and efficacy of yttrium ...... s with non-Hodgkin's lymphoma.
@en
P2093
Arturo Molina
Christos Emmanouilides
Gregory A Wiseman
M Wayne Saville
Russell Schilder
Thomas E Witzig
P304
P356
10.1089/CBR.2007.359
P577
2007-10-01T00:00:00Z